(Q37719559)

22 August 2017

1 reference

title

Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

22 August 2017

main subject

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

0 references

stem cell transplantation

1 reference

Huayong Zhang

1

1 reference

22 August 2017

Xiaofeng Zeng

series ordinal

2

1 reference

22 August 2017

Lingyun Sun

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Expert Opinion on Biological Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

701-709

1 reference

Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mortality in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Stem cell transplantation for rheumatic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mesenchymal stem cells: a new strategy for immunosuppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mesenchymal stem cells in immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

MHC II gene knockout in tissue engineering may prevent immune rejection of transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Expression of autoimmunity by marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Rationale for bone marrow transplantation in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Autoimmune diseases as stem cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Autoimmune disease: is it a disorder of the microenvironment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Culture systems for pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Adult bone marrow stromal cells differentiate into neural cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mechanisms involved in the therapeutic properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Rituximab and lupus: Good in real life, bad in controlled trials. comment on the article by Lu et al

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003769816

10.1517/14712591003769816

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference